<http://webisa.webdatacommons.org/17159482>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<google.com> .
<http://webisa.webdatacommons.org/prov/489257320>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/17159482> .
<http://webisa.webdatacommons.org/prov/166752228>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/17159482> .
<http://webisa.webdatacommons.org/17159482>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/204397007>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/17159482> .
<http://webisa.webdatacommons.org/17159482>	<http://www.w3.org/ns/prov#value>	"Likewise, the therapeutic agents 16 retained on or within the drug delivery unit 10 can involve liquids, solids (e.g. powders, crystals, and the like), gels, pastes, and any other forms which are necessary as determined by routine preliminary testing." .